top of page

Kushy Pies Jumps into the Rotation




Episode recap: On this week’s episode of The Rotation, Executive Director Christopher Cano, Political/Policy Director Gary Stein, and host Carlos Hermida welcomed Hannah (chef/CEO) and Vinnie from Kushy Pies for a conversation that cut through the noise: consumer safety, honest labeling, and the role of small businesses in a market increasingly shaped by corporate lobbying.

Below are the big takeaways—and how you can help Suncoast NORML fight for safe, affordable access and the right to grow at home.



Spotlight: Kushy Pies and the Case for Craft, Not Hype

What sets Kushy Pies apart?

  • Precise dosing & clear labeling. Hannah emphasized responsible first-time use (start at 5 mg) and transparent COAs so people know exactly what they’re consuming. No guesswork, no “mystery edibles.”

  • Taste > chlorophyll. The culinary goal is dessert-forward edibles you actually want to finish—without that bitter, “green” aftertaste.

  • Compliance matters. FDACS-compliant, child-resistant packaging and plain labeling (with a red THC warning for visibility) keep products legal and understandable.

  • Options for everyone. Infused and non-infused desserts (plus iced teas and lemonades) make it easy for consumers to choose the experience they want.

Why this matters: Too many “edibles” still rely on home-brew methods with no reliable dosing. Quality-first small companies like Kushy Pies raise the standard—proving you don’t need flashy packaging to deliver safe, consistent experiences.


The Bigger Picture: What Consumers Actually Need

1) Home grow + legal access = safer markets. The team underscored a simple truth: if you want clean, trustworthy cannabis, you need legal retail access and the right to grow your own. That combination reduces unregulated risks, curbs sensational myths, and gives consumers real choice.

2) Corporate cannabis can’t legislate away craft. We discussed how some MSOs try to “win” with bans and lobbying rather than quality. That hurts small businesses and consumers. If you want customer loyalty, make better products—don’t kneecap the competition.

3) Label inflation and lab games .Potency numbers shouldn’t be marketing props. Cherry-picking the “hottest” nug and calling it the whole batch misleads patients and drives price inflation without improving outcomes.

4) Fentanyl panic ≠ cannabis policy. The panel pushed back on rumor-driven headlines. Evidence shows fentanyl almost never co-occurs in cannabis seizures; policy should be based on data, not fear.

5) Edibles are harm-reduction tools for some consumers. For people who avoid smoking or are cutting back on alcohol, properly dosed edibles offer a predictable, longer-lasting alternative—one reason beverage and alcohol companies are eyeing the space.


Market Reality Check: Prices, Products, and Over-Infusing

  • Price whiplash across cities. Chicago’s legal flower can still run like Florida medical pricing, while DC’s competitive gray/“gifting” market pushes ounces down around the cost of a single IL eighth. Consumers notice.

  • The “more is more” trap. From terp-drenched pre-rolls to “snow-capped” cones, too much infusion can turn into all flavor, no finesse. Chasing numbers often ignores experience—and respiratory comfort.


Policy Front: The Wins, the Setbacks, and the Work Ahead

  • Public support keeps rising. National polling continues to show strong majorities for legalization—especially among under-70 voters.

  • Court wins for rights. Recent appellate rulings affirm that patients shouldn’t be second-class citizens under the Second Amendment.

  • State turbulence continues. While some states expand access (adding conditions, more licenses, or new forms), others undercut voter mandates with restrictive rules—limiting flower, capping license counts, or micromanaging physician recommendations.

  • The MORE Act returns. Descheduling—not rescheduling—remains the gold standard: removing cannabis from the Controlled Substances Act, expungements, VA access, and reinvestment where prohibition hit hardest.

Bottom line: The fight in 2025–26 will be about truth in labeling, home grow, equitable access, and keeping small businesses in the game. That only happens if advocates stay organized and loud.


Event Plug: Puff N Paint — Powered by Kushy Pies

Saturday, October 4 • Battle Buds (2608 N Armenia Ave, Tampa)

  • VIP “trap bag” (limited to 20) curated by Kushy Pies

  • Pre-sketched canvases (this time laser-engraved by Hannah’s new @laseredup project), paints & brushes provided

  • Infused & non-infused treats available; chill outdoor vibe with music

  • Members get free general admission; painting and VIP tickets available for purchase

  • All proceeds support Suncoast NORML’s legalization and patient-protection work

Grab tickets and membership at suncoastnorml.org.


How You Can Help Right Now

  • Join Suncoast NORML. Membership keeps our advocacy independent and effective. It also unlocks free GA to events like Puff N Paint.

  • Show up. Whether it’s hearings, town halls, or community events—your presence moves votes.

  • Share the facts. Push back—politely but firmly—when myths spread. Cite evidence. Protect patients.

  • Support small. Choose businesses that publish COAs, dose responsibly, and prioritize consumer education.


Call to Action: Join Suncoast NORML Today

If you believe in home grow, truth in labeling, and a consumer-first cannabis market, we need you on the team. Become a member, donate, or volunteer at suncoastnorml.org—and let’s legalize it the right way.

 
 
 

Comments


bottom of page